0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA Sequencing In Drug Discovery Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27H5646
Home | Market Reports | Science| Biological Sciences
Global DNA Sequencing In Drug Discovery Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global DNA Sequencing In Drug Discovery Market Research Report 2025

Code: QYRE-Auto-27H5646
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

DNA Sequencing In Drug Discovery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

DNA Sequencing In Drug Discovery Market

DNA Sequencing In Drug Discovery Market

The global market for DNA Sequencing In Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for DNA Sequencing In Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Sequencing In Drug Discovery.
The DNA Sequencing In Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Sequencing In Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Sequencing In Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of DNA Sequencing In Drug Discovery Market Report

Report Metric Details
Report Name DNA Sequencing In Drug Discovery Market
CAGR 5%
Segment by Type
  • Microarrays
  • Polymerase Chain Reaction (pcr) Techniques
Segment by Application
  • Pharmaceutical
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Siemens Healthcare Diagnostics, Promega Corporation, Nanogen, Inc., GVK Biosciences Private Limited, Illumina, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Beckman Coulter (Danaher Corporation), 454 Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of DNA Sequencing In Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the DNA Sequencing In Drug Discovery Market report?

Ans: The main players in the DNA Sequencing In Drug Discovery Market are Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Siemens Healthcare Diagnostics, Promega Corporation, Nanogen, Inc., GVK Biosciences Private Limited, Illumina, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Beckman Coulter (Danaher Corporation), 454 Life Sciences

What are the Application segmentation covered in the DNA Sequencing In Drug Discovery Market report?

Ans: The Applications covered in the DNA Sequencing In Drug Discovery Market report are Pharmaceutical, Other

What are the Type segmentation covered in the DNA Sequencing In Drug Discovery Market report?

Ans: The Types covered in the DNA Sequencing In Drug Discovery Market report are Microarrays, Polymerase Chain Reaction (pcr) Techniques

Recommended Reports

Drug Discovery Tools

Gene and Nucleic Acid

Diagnostic Technology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Sequencing In Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microarrays
1.2.3 Polymerase Chain Reaction (pcr) Techniques
1.3 Market by Application
1.3.1 Global DNA Sequencing In Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Sequencing In Drug Discovery Market Perspective (2020-2031)
2.2 Global DNA Sequencing In Drug Discovery Growth Trends by Region
2.2.1 Global DNA Sequencing In Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 DNA Sequencing In Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 DNA Sequencing In Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 DNA Sequencing In Drug Discovery Market Dynamics
2.3.1 DNA Sequencing In Drug Discovery Industry Trends
2.3.2 DNA Sequencing In Drug Discovery Market Drivers
2.3.3 DNA Sequencing In Drug Discovery Market Challenges
2.3.4 DNA Sequencing In Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Sequencing In Drug Discovery Players by Revenue
3.1.1 Global Top DNA Sequencing In Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global DNA Sequencing In Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global DNA Sequencing In Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DNA Sequencing In Drug Discovery Revenue
3.4 Global DNA Sequencing In Drug Discovery Market Concentration Ratio
3.4.1 Global DNA Sequencing In Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Sequencing In Drug Discovery Revenue in 2024
3.5 Global Key Players of DNA Sequencing In Drug Discovery Head office and Area Served
3.6 Global Key Players of DNA Sequencing In Drug Discovery, Product and Application
3.7 Global Key Players of DNA Sequencing In Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Sequencing In Drug Discovery Breakdown Data by Type
4.1 Global DNA Sequencing In Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global DNA Sequencing In Drug Discovery Forecasted Market Size by Type (2026-2031)
5 DNA Sequencing In Drug Discovery Breakdown Data by Application
5.1 Global DNA Sequencing In Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global DNA Sequencing In Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America DNA Sequencing In Drug Discovery Market Size (2020-2031)
6.2 North America DNA Sequencing In Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America DNA Sequencing In Drug Discovery Market Size by Country (2020-2025)
6.4 North America DNA Sequencing In Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Sequencing In Drug Discovery Market Size (2020-2031)
7.2 Europe DNA Sequencing In Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe DNA Sequencing In Drug Discovery Market Size by Country (2020-2025)
7.4 Europe DNA Sequencing In Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Sequencing In Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific DNA Sequencing In Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific DNA Sequencing In Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific DNA Sequencing In Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Sequencing In Drug Discovery Market Size (2020-2031)
9.2 Latin America DNA Sequencing In Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America DNA Sequencing In Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America DNA Sequencing In Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Sequencing In Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa DNA Sequencing In Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa DNA Sequencing In Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa DNA Sequencing In Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Sigma-Aldrich Corporation
11.2.1 Sigma-Aldrich Corporation Company Details
11.2.2 Sigma-Aldrich Corporation Business Overview
11.2.3 Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Introduction
11.2.4 Sigma-Aldrich Corporation Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.2.5 Sigma-Aldrich Corporation Recent Development
11.3 Siemens Healthcare Diagnostics
11.3.1 Siemens Healthcare Diagnostics Company Details
11.3.2 Siemens Healthcare Diagnostics Business Overview
11.3.3 Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Introduction
11.3.4 Siemens Healthcare Diagnostics Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.3.5 Siemens Healthcare Diagnostics Recent Development
11.4 Promega Corporation
11.4.1 Promega Corporation Company Details
11.4.2 Promega Corporation Business Overview
11.4.3 Promega Corporation DNA Sequencing In Drug Discovery Introduction
11.4.4 Promega Corporation Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.4.5 Promega Corporation Recent Development
11.5 Nanogen, Inc.
11.5.1 Nanogen, Inc. Company Details
11.5.2 Nanogen, Inc. Business Overview
11.5.3 Nanogen, Inc. DNA Sequencing In Drug Discovery Introduction
11.5.4 Nanogen, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.5.5 Nanogen, Inc. Recent Development
11.6 GVK Biosciences Private Limited
11.6.1 GVK Biosciences Private Limited Company Details
11.6.2 GVK Biosciences Private Limited Business Overview
11.6.3 GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Introduction
11.6.4 GVK Biosciences Private Limited Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.6.5 GVK Biosciences Private Limited Recent Development
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Details
11.7.2 Illumina, Inc. Business Overview
11.7.3 Illumina, Inc. DNA Sequencing In Drug Discovery Introduction
11.7.4 Illumina, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.7.5 Illumina, Inc. Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Details
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics DNA Sequencing In Drug Discovery Introduction
11.8.4 Roche Diagnostics Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.8.5 Roche Diagnostics Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Details
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Beckman Coulter (Danaher Corporation)
11.10.1 Beckman Coulter (Danaher Corporation) Company Details
11.10.2 Beckman Coulter (Danaher Corporation) Business Overview
11.10.3 Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Introduction
11.10.4 Beckman Coulter (Danaher Corporation) Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.10.5 Beckman Coulter (Danaher Corporation) Recent Development
11.11 454 Life Sciences
11.11.1 454 Life Sciences Company Details
11.11.2 454 Life Sciences Business Overview
11.11.3 454 Life Sciences DNA Sequencing In Drug Discovery Introduction
11.11.4 454 Life Sciences Revenue in DNA Sequencing In Drug Discovery Business (2020-2025)
11.11.5 454 Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global DNA Sequencing In Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Microarrays
 Table 3. Key Players of Polymerase Chain Reaction (pcr) Techniques
 Table 4. Global DNA Sequencing In Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global DNA Sequencing In Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global DNA Sequencing In Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global DNA Sequencing In Drug Discovery Market Share by Region (2020-2025)
 Table 8. Global DNA Sequencing In Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global DNA Sequencing In Drug Discovery Market Share by Region (2026-2031)
 Table 10. DNA Sequencing In Drug Discovery Market Trends
 Table 11. DNA Sequencing In Drug Discovery Market Drivers
 Table 12. DNA Sequencing In Drug Discovery Market Challenges
 Table 13. DNA Sequencing In Drug Discovery Market Restraints
 Table 14. Global DNA Sequencing In Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global DNA Sequencing In Drug Discovery Market Share by Players (2020-2025)
 Table 16. Global Top DNA Sequencing In Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Sequencing In Drug Discovery as of 2024)
 Table 17. Ranking of Global Top DNA Sequencing In Drug Discovery Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by DNA Sequencing In Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of DNA Sequencing In Drug Discovery, Headquarters and Area Served
 Table 20. Global Key Players of DNA Sequencing In Drug Discovery, Product and Application
 Table 21. Global Key Players of DNA Sequencing In Drug Discovery, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global DNA Sequencing In Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global DNA Sequencing In Drug Discovery Revenue Market Share by Type (2020-2025)
 Table 25. Global DNA Sequencing In Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global DNA Sequencing In Drug Discovery Revenue Market Share by Type (2026-2031)
 Table 27. Global DNA Sequencing In Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global DNA Sequencing In Drug Discovery Revenue Market Share by Application (2020-2025)
 Table 29. Global DNA Sequencing In Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global DNA Sequencing In Drug Discovery Revenue Market Share by Application (2026-2031)
 Table 31. North America DNA Sequencing In Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America DNA Sequencing In Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America DNA Sequencing In Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe DNA Sequencing In Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe DNA Sequencing In Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe DNA Sequencing In Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific DNA Sequencing In Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific DNA Sequencing In Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific DNA Sequencing In Drug Discovery Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DNA Sequencing In Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America DNA Sequencing In Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America DNA Sequencing In Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa DNA Sequencing In Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa DNA Sequencing In Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa DNA Sequencing In Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Thermo Fisher Scientific, Inc. Company Details
 Table 47. Thermo Fisher Scientific, Inc. Business Overview
 Table 48. Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Product
 Table 49. Thermo Fisher Scientific, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 50. Thermo Fisher Scientific, Inc. Recent Development
 Table 51. Sigma-Aldrich Corporation Company Details
 Table 52. Sigma-Aldrich Corporation Business Overview
 Table 53. Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Product
 Table 54. Sigma-Aldrich Corporation Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 55. Sigma-Aldrich Corporation Recent Development
 Table 56. Siemens Healthcare Diagnostics Company Details
 Table 57. Siemens Healthcare Diagnostics Business Overview
 Table 58. Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Product
 Table 59. Siemens Healthcare Diagnostics Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 60. Siemens Healthcare Diagnostics Recent Development
 Table 61. Promega Corporation Company Details
 Table 62. Promega Corporation Business Overview
 Table 63. Promega Corporation DNA Sequencing In Drug Discovery Product
 Table 64. Promega Corporation Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 65. Promega Corporation Recent Development
 Table 66. Nanogen, Inc. Company Details
 Table 67. Nanogen, Inc. Business Overview
 Table 68. Nanogen, Inc. DNA Sequencing In Drug Discovery Product
 Table 69. Nanogen, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 70. Nanogen, Inc. Recent Development
 Table 71. GVK Biosciences Private Limited Company Details
 Table 72. GVK Biosciences Private Limited Business Overview
 Table 73. GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Product
 Table 74. GVK Biosciences Private Limited Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 75. GVK Biosciences Private Limited Recent Development
 Table 76. Illumina, Inc. Company Details
 Table 77. Illumina, Inc. Business Overview
 Table 78. Illumina, Inc. DNA Sequencing In Drug Discovery Product
 Table 79. Illumina, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 80. Illumina, Inc. Recent Development
 Table 81. Roche Diagnostics Company Details
 Table 82. Roche Diagnostics Business Overview
 Table 83. Roche Diagnostics DNA Sequencing In Drug Discovery Product
 Table 84. Roche Diagnostics Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 85. Roche Diagnostics Recent Development
 Table 86. Bio-Rad Laboratories, Inc. Company Details
 Table 87. Bio-Rad Laboratories, Inc. Business Overview
 Table 88. Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Product
 Table 89. Bio-Rad Laboratories, Inc. Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 90. Bio-Rad Laboratories, Inc. Recent Development
 Table 91. Beckman Coulter (Danaher Corporation) Company Details
 Table 92. Beckman Coulter (Danaher Corporation) Business Overview
 Table 93. Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Product
 Table 94. Beckman Coulter (Danaher Corporation) Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 95. Beckman Coulter (Danaher Corporation) Recent Development
 Table 96. 454 Life Sciences Company Details
 Table 97. 454 Life Sciences Business Overview
 Table 98. 454 Life Sciences DNA Sequencing In Drug Discovery Product
 Table 99. 454 Life Sciences Revenue in DNA Sequencing In Drug Discovery Business (2020-2025) & (US$ Million)
 Table 100. 454 Life Sciences Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. DNA Sequencing In Drug Discovery Picture
 Figure 2. Global DNA Sequencing In Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DNA Sequencing In Drug Discovery Market Share by Type: 2024 VS 2031
 Figure 4. Microarrays Features
 Figure 5. Polymerase Chain Reaction (pcr) Techniques Features
 Figure 6. Global DNA Sequencing In Drug Discovery Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global DNA Sequencing In Drug Discovery Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Case Studies
 Figure 9. Other Case Studies
 Figure 10. DNA Sequencing In Drug Discovery Report Years Considered
 Figure 11. Global DNA Sequencing In Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global DNA Sequencing In Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global DNA Sequencing In Drug Discovery Market Share by Region: 2024 VS 2031
 Figure 14. Global DNA Sequencing In Drug Discovery Market Share by Players in 2024
 Figure 15. Global Top DNA Sequencing In Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Sequencing In Drug Discovery as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by DNA Sequencing In Drug Discovery Revenue in 2024
 Figure 17. North America DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America DNA Sequencing In Drug Discovery Market Share by Country (2020-2031)
 Figure 19. United States DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe DNA Sequencing In Drug Discovery Market Share by Country (2020-2031)
 Figure 23. Germany DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific DNA Sequencing In Drug Discovery Market Share by Region (2020-2031)
 Figure 31. China DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America DNA Sequencing In Drug Discovery Market Share by Country (2020-2031)
 Figure 39. Mexico DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa DNA Sequencing In Drug Discovery Market Share by Country (2020-2031)
 Figure 43. Turkey DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE DNA Sequencing In Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Thermo Fisher Scientific, Inc. Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 47. Sigma-Aldrich Corporation Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 48. Siemens Healthcare Diagnostics Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 49. Promega Corporation Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 50. Nanogen, Inc. Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 51. GVK Biosciences Private Limited Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 52. Illumina, Inc. Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 53. Roche Diagnostics Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 54. Bio-Rad Laboratories, Inc. Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 55. Beckman Coulter (Danaher Corporation) Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 56. 454 Life Sciences Revenue Growth Rate in DNA Sequencing In Drug Discovery Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS